Navigation Links
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

s planned New Drug Application

submission to the FDA and for commercialization of lorcaserin after

regulatory marketing approval. The agreements included a long-term

supply agreement for Arena's purchase of lorcaserin active

pharmaceutical ingredient, or API, the purchase of certain finishing

facility assets and technology, including fixtures, equipment, other

personal property and real estate assets, a contract manufacturing

agreement whereby Arena will manufacture certain products for

Siegfried, and a services agreement.

-- Reported positive Phase 1a clinical trial results of APD791, Arena's

oral, internally discovered drug candidate intended for the treatment

and prevention of arterial thromboembolic diseases, and initiated a

Phase 1b clinical trial to further evaluate this drug candidate.

-- Announced that initial clinical trial results for APD668, an oral drug

candidate discovered by Arena and investigated for the treatment of

type 2 diabetes under its partnership with Ortho-McNeil, suggest that

the Glucose-Dependent Insulinotropic Receptor, or GDIR, may improve

glucose control in patients with type 2 diabetes. Based on the data

from those studies, Ortho-McNeil put APD668 on hold and has advanced a

potentially more potent Arena-discovered GDIR agonist into preclinical

development.

Outlook for 2008

Arena expects to use cash, cash equivalents and short-term investments of approximately $190 to $210 million for its operating activities in 2008 and approximately $38 to $44 million for capital expenditures, which includes the cash payable at closing for the acquisition from Siegfried Ltd of a drug product finishing facility and related assets, which closed in January 2008. This assumes that Arena, and not a partner, continues to advance and fund its planned 20
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 OncLive® is ... Center at Thomas Jefferson University has joined its ... Strategic Alliance Partnership program, the Sidney Kimmel Cancer ... raise awareness of the Center’s cutting-edge research programs, ... Clinicians and other health care professionals from the ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The 9th Annual ... take place at the Congress Center Basel, ... now available at http://www.abim.ch . ... from all over the globe will exchange ... products and developments on the world market. ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The Asia-Pacific ... Analytics market in Asia-Pacific with analysis and forecast of ... million in 2014 to $208 million by 2019, at ... 2014 to 2019. , Browse through the TOC of ... idea of the in-depth analysis provided. It also provides ...
(Date:10/19/2014)... 2014 According to market research ... WLAN Controllers; Wireless gateways)]- Global Advancements, Forecasts and ... global Outdoor Wi-Fi market with analysis and forecasting ... also identifies the drivers and the restrains for ... opportunities and challenges. , Browse 65 market data ...
Breaking Biology Technology:Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 2Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 3Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 4
... EraGen Biosciences, Inc. announced today that it has developed ... technology. The test is now in the hands of USAMRIID ... being shipped to WHO Central Public Health Laboratory (UK) and ... recent sequencing of the SARS genome, EraGen went to work ...
... being held to solicit public sentiment on Assembly Bill ... . The bills were introduced to the state legislature in ... parthenogenesis (the process of manipulating the genetic material of a ... from any other cell, in a way that causes the ...
... April 29 Berbee Information Networks Corporation, a leading Midwest ... announced today that it has been selected by Microsoft ... 2003 and Visual Studio .NET 2003 Launch. , ... Midwest Express Center inMilwaukee, Wisconsin, Berbee will speak in ...
Cached Biology Technology:EraGen Biosciences Ships SARS Diagnostic Test in Record Time 2Public Hearing Held for controversial anti-cloning bills 2Public Hearing Held for controversial anti-cloning bills 3Public Hearing Held for controversial anti-cloning bills 4
(Date:10/16/2014)... challenged conventional thinking on how the bowel lining develops ... how bowel cancer starts. , The researchers produced evidence ... the ,crypts, that are a feature of the bowel ... bowel cancer development, a controversial finding as scientists are ... 3D imaging technologies, Dr Chin Wee Tan and Professor ...
(Date:10/15/2014)... 2014 Sandata Technologies, LLC, an industry ... care, today announced it released a case study ... Visit Verification™ Solution (EVV™)  for Quality Care Services, ... company founded in 1996 and has five locations ... The study details the challenges facing Quality ...
(Date:10/15/2014)... have linked increased resistance to bacterial pneumonia in female ... hormone estrogen. , Females are naturally more resistant to ... scientists has shown that increased resistance to bacterial pneumonia ... oxide synthase 3 (NOS3). They also show that this ... female sex hormone estrogen. , The team, lead by ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2Sandata Announces Case Study with Quality Care Services, Inc. 2
... computational and experimental researchers is needed to make ... understanding how epigenetic marks contribute to regulation of ... organised by the European Science Foundation (ESF), Computational ... Transcription Regulation. , Epigenetics studies features of the ...
... April) at the UK National Stem Cell Network Annual ... University describes his work to investigate a mechanism that ... Together with his colleague Owen Sansom from the University ... wrong and a crucial gene called Apc is lost ...
... into the brain could dramatically reduce damage caused by ... Meeting will hear today (10 April). Speaking at ... Institute of Psychiatry will explain how combining scaffold microparticles ... tissue. Strokes cause temporary loss of blood supply ...
Cached Biology News:Computation to unravel how genes are regulated and shed light on how cells become different 2Computation to unravel how genes are regulated and shed light on how cells become different 3Stem cells and cancer: cancer pathways that also control the adult stem cell population 2Scientists ask whether microscaffolding can help stem cells rebuild brain after stroke damage 2
... C1 Plus is a modular confocal system ... with an ultra-compact and lightweight design. The ... Plusboost optical performance to 400nm andits bi-directional ... support for X and Y scan axes ...
... continue to grow, the need for greater ... become necessary, especially when discerning very similar ... C1si Confocal Microscope System gives you a ... not available in conventional confocal systems, with ...
... This microscope is described by end-users to ... incorporates the fundamentals of light microscopy and ... small footprint, it does not require much ... a busy lab environment. The DM-BA300 combines ...
... Drive for individual and parallel agitation control ... of DASGIP vessels, featuring range of stirring ... to 16 overhead drives can be operated ... fedbatch-pro® and cellferm-pro® for microbiology and cell ...
Biology Products: